1778 related articles for article (PubMed ID: 28474673)
1. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.
Chung W; Eum HH; Lee HO; Lee KM; Lee HB; Kim KT; Ryu HS; Kim S; Lee JE; Park YH; Kan Z; Han W; Park WY
Nat Commun; 2017 May; 8():15081. PubMed ID: 28474673
[TBL] [Abstract][Full Text] [Related]
2. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
[TBL] [Abstract][Full Text] [Related]
4. ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer.
Beltjens F; Molly D; Bertaut A; Richard C; Desmoulins I; Loustalot C; Charon-Barra C; Courcet E; Bergeron A; Ladoire S; Jankowski C; Boidot R; Arnould L
Int J Cancer; 2021 Jul; 149(1):200-213. PubMed ID: 33634878
[TBL] [Abstract][Full Text] [Related]
5. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
6. Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.
Avigdor BE; Beierl K; Gocke CD; Zabransky DJ; Cravero K; Kyker-Snowman K; Button B; Chu D; Croessmann S; Cochran RL; Connolly RM; Park BH; Wheelan SJ; Cimino-Mathews A
Clin Cancer Res; 2017 Aug; 23(16):4875-4884. PubMed ID: 28424200
[No Abstract] [Full Text] [Related]
7. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy.
de Boo L; Cimino-Mathews A; Lubeck Y; Daletzakis A; Opdam M; Sanders J; Hooijberg E; van Rossum A; Loncova Z; Rieder D; Trajanoski Z; Vollebergh M; Sobral-Leite M; van de Vijver K; Broeks A; van der Wiel R; van Tinteren H; Linn S; Horlings HM; Kok M
Eur J Cancer; 2020 Mar; 127():240-250. PubMed ID: 31956037
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.
Zhao H; Chen D; Wang J; Yin Y; Gao Q; Zhang Y
Int J Clin Exp Pathol; 2014; 7(2):670-6. PubMed ID: 24551288
[TBL] [Abstract][Full Text] [Related]
9. Local iron homeostasis in the breast ductal carcinoma microenvironment.
Marques O; Porto G; Rêma A; Faria F; Cruz Paula A; Gomez-Lazaro M; Silva P; Martins da Silva B; Lopes C
BMC Cancer; 2016 Mar; 16():187. PubMed ID: 26944411
[TBL] [Abstract][Full Text] [Related]
10. Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments.
Yuan Y; Zhang S; Huang J
Mol Biol Rep; 2024 Jun; 51(1):720. PubMed ID: 38824268
[TBL] [Abstract][Full Text] [Related]
11. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; Doughty JC; McMillan DC
Br J Cancer; 2012 Aug; 107(5):864-73. PubMed ID: 22878371
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.
Azizi E; Carr AJ; Plitas G; Cornish AE; Konopacki C; Prabhakaran S; Nainys J; Wu K; Kiseliovas V; Setty M; Choi K; Fromme RM; Dao P; McKenney PT; Wasti RC; Kadaveru K; Mazutis L; Rudensky AY; Pe'er D
Cell; 2018 Aug; 174(5):1293-1308.e36. PubMed ID: 29961579
[TBL] [Abstract][Full Text] [Related]
13. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype.
Patani N; Barbashina V; Lambros MB; Gauthier A; Mansour M; Mackay A; Reis-Filho JS
J Clin Pathol; 2011 Sep; 64(9):822-8. PubMed ID: 21676924
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.
Richard F; Majjaj S; Venet D; Rothé F; Pingitore J; Boeckx B; Marchio C; Clatot F; Bertucci F; Mariani O; Galant C; Eynden GVD; Salgado R; Biganzoli E; Lambrechts D; Vincent-Salomon A; Pruneri G; Larsimont D; Sotiriou C; Desmedt C
Clin Cancer Res; 2020 Dec; 26(23):6254-6265. PubMed ID: 32943456
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
[TBL] [Abstract][Full Text] [Related]
17. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?
Jones T; Neboori H; Wu H; Yang Q; Haffty BG; Evans S; Higgins S; Moran MS
Ann Surg Oncol; 2013 Sep; 20(9):2866-72. PubMed ID: 23661183
[TBL] [Abstract][Full Text] [Related]
18. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and
the correlation among them].
Li X; Wang Q; Fu L; Liu M; Yu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
[TBL] [Abstract][Full Text] [Related]
19. The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Waks AG; Stover DG; Guerriero JL; Dillon D; Barry WT; Gjini E; Hartl C; Lo W; Savoie J; Brock J; Wesolowski R; Li Z; Damicis A; Philips AV; Wu Y; Yang F; Sullivan A; Danaher P; Brauer HA; Osmani W; Lipschitz M; Hoadley KA; Goldberg M; Perou CM; Rodig S; Winer EP; Krop IE; Mittendorf EA; Tolaney SM
Clin Cancer Res; 2019 Aug; 25(15):4644-4655. PubMed ID: 31061067
[TBL] [Abstract][Full Text] [Related]
20. Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer.
Asano Y; Kashiwagi S; Goto W; Kurata K; Noda S; Takashima T; Onoda N; Tanaka S; Ohsawa M; Hirakawa K
Br J Surg; 2016 Jun; 103(7):845-54. PubMed ID: 26953091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]